Government Affairs
Refine Search
Generics
US Representatives Steve Stivers (Republican, Ohio) Peter Welch (Democrat, Vermont) on Thursday joined forces to introduce the Fair Access for Safe and Timely (FAST) Generics Act to increase consumer access to generic drugs, boost market competition and ultimately save consumers money. 19 September 2014
Pharmaceutical
Russia's pharmaceutical market has been growing faster over recent years. The Pharma 2020 Strategy provides incentives for local producers to develop original and generic drugs for both domestic and foreign markets. 17 September 2014
Pharmaceutical
Consumer advocacy group Health Action International says it is “appalled” by the European Commission’s opaque and unjustified decision to move SANCO Units D5 (Medicinal Products – Authorizations, European Medicines Agency) and D6 (Medicinal Products – Quality, Safety and Efficacy) from the Directorate General (DG) for Health and Consumers to DG Enterprise and Industry. 12 September 2014
Pharmaceutical
The Russian government has no plans to impose a ban on the pharmaceutical imports from the European Union and the USA, as proposed by some local top-officials, as a response to the next package of sanctions against Russia, which was yesterday approved by the EU. 12 September 2014
article
We take a look at the week's top stories. 11 September 2014
Pharmaceutical
The Associated Chambers of Commerce and Industry of India (ASSOCHAM ) has expressed concern at the setback to clinical trials for new pharmaceutical drugs in the country and has called for several changes in the Drugs and Cosmetics Amendment Rules to meet industry concerns about these trials. 10 September 2014
Biotechnology
Australian medical bodies are collaborating to advocate for the Medical Research Future Fund (MRFF) proposed by the government. 2 September 2014
Pharmaceutical
New figures from Danish pharmaceutical industry trade groups Lif and Dansk Biotek reveal that 296 clinical drug trials were in progress in Denmark in 2013. It would appear that the sharp drop in the number of clinical drug trials seen between 2007 and 2010 has now finally come to an end, with stability returning to the area over the past two years. 1 September 2014
Pharmaceutical
Non-governmental organizations in India have jointly issued a letter calling on the country’s government to expand the scope of price control by bringing other essential and life saving medicines under price regulation in order to protect patients from overcharging and to promote public health. 22 August 2014
Pharmaceutical
Ukraine plans to ban pharmaceutical imports from Russia, except 20 vital drugs, the analogues of which are not produced in Ukraine, according to Oleg Musy, Ukraine’s Health Minister. 11 August 2014
Pharmaceutical
The Russian Federation Council, the upper house of the Federal Assembly of the country, has put forward a proposal to restrict imports of drugs from Western countries to Russia, in response to sanctions, imposed on the country by the USA and the European Union, reports The Pharma Letter’s Russia correspondent. 11 August 2014
Biosimilars
US Senators Lamar Alexander (Republican, Tennessee) and Orrin Hatch (Rep, Utah) have led colleagues in calling on the Obama administration to release guidance documents on biosimilar drug approvals. 6 August 2014
Generics
South African trade group the National Association of Pharmaceutical Manufacturers (NAPM) has proposed a zero Value Added Tax (VAT) rating of medicines in its submission to the Davis Tax Committee, tasked with assessing the country’s tax policy framework and its role in supporting the objectives of inclusive growth, employment, development and fiscal sustainability in South Africa. 22 July 2014
Pharmaceutical
All Australian Health Ministers have committed to working towards the virtual elimination of new Australian HIV transmissions by the end of 2020, said the Department of Health and Ageing over the weekend. 21 July 2014
Biotechnology
Adding to previous criticism from the likes of the medical humanitarian organization Medecins Sans Frontieres (MSF) and the World Health Organization, US Senate Finance Committee Chairman Ron Wyden (Democrat, Oregon) and senior Finance Committee member Chuck Grassley (Republican, Iowa) on Friday requested detailed pricing information from US anti-virals specialist Gilead Sciences on its costly new hepatitis C virus (HCV) drug Sovaldi (sofosbuvir). 12 July 2014
Pharmaceutical
A wide-raging report published today by the UK House of Commons Science and Technology Select Committee report on Antimicrobial Resistance has welcomed Prime Minister David Cameron’s decision to appoint Jim O’Neill, a former Goldman Sachs chief economist, to lead a team to spur the development of new drugs to prevent antibiotic resistance. 7 July 2014
Generics
South Africa’s National Association of Pharmaceutical Manufacturer’s has appointed its new Executive Council, which has been tasked with strengthening the association’s strategic position within the pharmaceutical industry whilst representing the interests of its members and the broader public. 3 July 2014
Pharmaceutical
A new KPMG study shows that R&D investments made by Canada's innovative pharmaceutical sector continue to be chronically under-reported by the government of Canada at an increasing amount year-over-year. 30 June 2014
Pharmaceutical
In order to make drugs more affordable to the country’s public, the Indian government is likely to hike the number of drugs that come under the category of essential drugs, and place them under the ambit of price control, reports The Pharma Letter's India correspondent. Once implemented, the move would effectively result in drug prices sliding by 10% to 15%. 30 June 2014
Pharmaceutical
Encouraging private-sector innovation, making public research institutions more accountable and channelling more funds into the most promising R&D projects would help restore France’s former prowess in science and technology, a new OECD (Organization for Economic Cooperation and Development) report says. 27 June 2014
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze